financetom
Business
financetom
/
Business
/
Mr. Cooper Group Insider Sold Shares Worth $2,218,860, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Mr. Cooper Group Insider Sold Shares Worth $2,218,860, According to a Recent SEC Filing
May 10, 2024 1:04 AM

03:33 AM EDT, 05/10/2024 (MT Newswires) -- Michael R Rawls, Executive Vice President & Chief Executive Officer of Xome, on May 07, 2024, sold 27,000 shares in Mr. Cooper Group ( COOP ) for $2,218,860. Following the Form 4 filing with the SEC, Rawls has control over a total of 57,623 shares of the company, with 57,623 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/933136/000093313624000040/xslF345X03/wk-form4_1715299957.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Newport Exploration Provides Update on GOR Licenses in Cooper Basin in Australia
Newport Exploration Provides Update on GOR Licenses in Cooper Basin in Australia
Jun 24, 2024
06:29 AM EDT, 06/24/2024 (MT Newswires) -- Newport Exploration Ltd ( NWXPF ) over the weekend provided an update on its licenses in the Cooper basin in Australia, over which Newport has a 2.5% gross overriding royalty (GOR). The information in the update was reported by Beach Energy in a recent Strategic Review Outcomes Presentation that covered Beach's entire Australian...
What other health conditions are weight-loss drugs being tested for?
What other health conditions are weight-loss drugs being tested for?
Jun 24, 2024
(Adds trial results of Zepbound in sleep apnea in paragraphs 2 and 20) By Patrick Wingrove June 26 (Reuters) - Eli Lilly's ( LLY ) blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well as Novo Nordisk's rival medicines Ozempic and Wegovy are being studied to see whether they can improve health in other ways. Zepbound helped resolve moderate...
Target Joins Forces With Shopify to Bolster Target Plus Third-Party Marketplace
Target Joins Forces With Shopify to Bolster Target Plus Third-Party Marketplace
Jun 24, 2024
06:33 AM EDT, 06/24/2024 (MT Newswires) -- Target said on Monday that it teamed up with global commerce platform Shopify ( SHOP ) to add merchants to Target Plus, the retailer's third-party digital marketplace that has more than 2 million products. Some Shopify ( SHOP ) merchants will feature both online and in Target stores nationwide, the retailer said. ...
G1 Therapeutics' breast cancer therapy fails late-stage trial
G1 Therapeutics' breast cancer therapy fails late-stage trial
Jun 24, 2024
June 24 (Reuters) - G1 Therapeutics ( GTHX ) said on Monday its therapy for a type of breast cancer did not meet the main goal of overall survival in a late-stage trial. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved